Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii

BACKGROUND: We retrospectively analyzed the effect of tigecycline and cefoperazone/sulbactam therapies on the prognosis of patients with carbapenem-resistant Acinetobacter baumannii bloodstream infection (CRAB-BSI). METHODS: CRAB-BSI patients receiving tigecycline therapy or cefoperazone/sulbactam t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Resist Infect Control
Main Authors: Niu, Tianshui, Luo, Qixia, Li, Yaqing, Zhou, Yanzi, Yu, Wei, Xiao, Yonghong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6404342/
https://ncbi.nlm.nih.gov/pubmed/30886705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13756-019-0502-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados